Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04231097 · ClinicalTrials.gov registry record · NA
MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04231097: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04231097 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04231097, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Brief Summary: The aim of this study is to explore the initial feasibility and acceptability of (a) Mindfulness-Based Cognitive Therapy (MBCT) adapted for ACS patients; (b) the group videoconferencing delivery medium; and (c) dried blood spot research procedures, to inform refinements for a subsequent pilot RCT.
Interventions
- OTHER MBCT intervention for ACS patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-04-24 |
| Est. Completion | 2021-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04231097
The ClinicalTrials.gov registry entry for NCT04231097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MBCT intervention for ACS patients is the first listed.
NCT04231097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04231097 about?
NCT04231097 is a clinical study titled "MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms". Brief Summary: The aim of this study is to explore the initial feasibility and acceptability of (a) Mindfulness-Based Cognitive Therapy (MBCT) adapted for ACS patients; (b) the group videoconferencing delivery medium; and (c) dried blood spot research procedures, to inform refinements for a subseque...
What is the current status of trial NCT04231097?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-04-24. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04231097?
The interventions under investigation include: MBCT intervention for ACS patients (OTHER).
Who is sponsoring clinical trial NCT04231097?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.